首页 > 最新文献

Ophthalmic Plastic and Reconstructive Surgery最新文献

英文 中文
Photochemical Crosslinking of Tarsal Collagen as a Treatment for Eyelid Laxity: Evaluation in Ex Vivo Human Tissue. 光化学交联跗骨胶原蛋白治疗眼睑松弛:活体人体组织评估。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-05-09 DOI: 10.1097/IOP.0000000000002709
Alexandra I Manta, Nadja E Pop, Robert G Tripon, Florina Vultur, Shuko Suzuki, Bogdan A Cordos, Carmen C Radu, Timur Hogea, Cosmin Carasca, Karin U Horvath, George A Muntean, Vasile C Siserman, Ovidiu S Cotoi, Mark H B Radford, Traian V Chirila

Purpose: Experimental investigation in human eyelids to confirm that exposing excised tarsal plates to ultraviolet-A radiation can induce a stiffening effect through the riboflavin-photosensitized crosslinking of tarsal collagen.

Methods: Thirteen tarsal plates excised from nonfrozen human cadavers were irradiated with ultraviolet-A rays (365 nm wavelength) at an irradiance of 75 mW/cm 2 for 3 minutes, equivalent to a radiation fluence of 13.5 J/cm 2 , in the presence of a riboflavin derivative as a photosensitizer. The tensile stress (strength) and Young's modulus (stiffness) of both nonirradiated and irradiated specimens were measured with the BioTester 5000 in the uniaxial mode at a strain of 10% and analyzed statistically. Individual specimens excised from 2 cadavers were also examined by routine histopathologic protocols to assess the effect of radiation on the Meibomian glands and collagen organization.

Results: The irradiation enhanced both stiffness and strength of the human tarsal specimens, the difference between the test samples and controls being statistically significant ( p < 0.0002 for n = 13). Histology indicated no damage to tarsal connective tissue or to Meibomian glands, and revealed a more compact packing of the collagen network located around the glands, which may be beneficial. The existence of collagen compaction was also supported by the reduction of samples' thickness after irradiation ( p = 0.0645).

Conclusions: The irradiation of tarsal tissue with ultraviolet-A light of tarsus appears to be a safe and effective method for reducing eyelid laxity in human patients.

目的:对人类眼睑进行实验研究,以证实将切除的跗骨板置于紫外线-A 辐射下,可通过核黄素光敏化跗骨胶原交联诱导僵化效应:方法:在核黄素衍生物作为光敏剂存在的情况下,用75 mW/cm2辐照度的紫外线A射线(波长365 nm)照射13块从非冷冻人体尸体上切除的跗骨板3分钟,相当于13.5 J/cm2的辐射通量。使用 BioTester 5000 以 10% 的应变在单轴模式下测量了未受辐射和受辐射标本的拉伸应力(强度)和杨氏模量(刚度),并进行了统计分析。此外,还采用常规组织病理学方法检查了从 2 具尸体上切除的单个标本,以评估辐射对睑板腺和胶原组织的影响:辐照增强了人体跗骨标本的硬度和强度,试验样本与对照组之间的差异具有统计学意义(p < 0.0002,n = 13)。组织学检查表明,跗骨结缔组织或睑板腺未受损伤,并显示位于睑板腺周围的胶原蛋白网络更紧凑,这可能是有益的。辐照后样本厚度的减少(p = 0.0645)也证明了胶原压实的存在:结论:用紫外线 A 光照射跗骨组织似乎是减少人类眼睑松弛的一种安全有效的方法。
{"title":"Photochemical Crosslinking of Tarsal Collagen as a Treatment for Eyelid Laxity: Evaluation in Ex Vivo Human Tissue.","authors":"Alexandra I Manta, Nadja E Pop, Robert G Tripon, Florina Vultur, Shuko Suzuki, Bogdan A Cordos, Carmen C Radu, Timur Hogea, Cosmin Carasca, Karin U Horvath, George A Muntean, Vasile C Siserman, Ovidiu S Cotoi, Mark H B Radford, Traian V Chirila","doi":"10.1097/IOP.0000000000002709","DOIUrl":"10.1097/IOP.0000000000002709","url":null,"abstract":"<p><strong>Purpose: </strong>Experimental investigation in human eyelids to confirm that exposing excised tarsal plates to ultraviolet-A radiation can induce a stiffening effect through the riboflavin-photosensitized crosslinking of tarsal collagen.</p><p><strong>Methods: </strong>Thirteen tarsal plates excised from nonfrozen human cadavers were irradiated with ultraviolet-A rays (365 nm wavelength) at an irradiance of 75 mW/cm 2 for 3 minutes, equivalent to a radiation fluence of 13.5 J/cm 2 , in the presence of a riboflavin derivative as a photosensitizer. The tensile stress (strength) and Young's modulus (stiffness) of both nonirradiated and irradiated specimens were measured with the BioTester 5000 in the uniaxial mode at a strain of 10% and analyzed statistically. Individual specimens excised from 2 cadavers were also examined by routine histopathologic protocols to assess the effect of radiation on the Meibomian glands and collagen organization.</p><p><strong>Results: </strong>The irradiation enhanced both stiffness and strength of the human tarsal specimens, the difference between the test samples and controls being statistically significant ( p < 0.0002 for n = 13). Histology indicated no damage to tarsal connective tissue or to Meibomian glands, and revealed a more compact packing of the collagen network located around the glands, which may be beneficial. The existence of collagen compaction was also supported by the reduction of samples' thickness after irradiation ( p = 0.0645).</p><p><strong>Conclusions: </strong>The irradiation of tarsal tissue with ultraviolet-A light of tarsus appears to be a safe and effective method for reducing eyelid laxity in human patients.</p>","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":" ","pages":"28-35"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140899322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two-year Outcomes of Ultra-low-dose Radiotherapy in the Treatment of Ocular Adnexal B-cell Lymphomas. 超低剂量放疗治疗眼部附件B细胞淋巴瘤的两年疗效。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-08-19 DOI: 10.1097/IOP.0000000000002747
Alexandra I Manta, David J Schlect, Delia D Wang, Timothy J Sullivan

Background: This study focuses on the efficacy and 2-year outcomes of ultra-low-dose radiotherapy (RT) in treating primary and secondary ocular adnexal lymphoma (OAL).

Methods: A retrospective analysis was conducted on patients with OAL between 2017 and 2022, treated with 4 Gy of RT. The primary and secondary outcomes assessed were response rate, progression-free survival, and lymphoma-related death.

Results: Twenty-one patients with primary and secondary OAL of diverse, presentations, subtypes, and stages were included. The orbital tumors had an average size of 17 × 16 × 16 mm. Of the 14 primary OAL cases, 3 (14%) had T1N0M0 disease, 8 (38%) T2N0M0, and 3 (14%) T3N0M0 (AJCC 8th edition staging); of the 7 secondary OALs, 4 (19%) were stage IE, 2 (10%) stage IIE, and 1 (5%) stage IIIE (Ann Arbor staging). Ultra-low-dose RT yielded a 95% complete response rate and 100% progression-free survival rates, both locally and systemically at 2 years. Mild dry eyes were reported in 14% of patients as a late treatment toxicity.

Conclusions: Ultra-low-dose RT emerges as an effective and well-tolerated treatment approach for OAL. Our findings support the use of 4 Gy, showcasing high complete response rates (95%) and durable disease control without significant local relapses over an average follow up of 27 months. Our results align with earlier investigations, validating the curative potential of ultra-low-dose RT and reinforcing the concept of achieving favorable outcomes with minimal intervention. This approach may potentially alleviate the burden of long-term ocular side effects associated with higher radiation doses, enhancing the overall quality of life for OAL patients.

背景:本研究主要探讨超低剂量放射治疗(RT)治疗原发性和继发性眼附件淋巴瘤(OAL)的疗效和两年后的结果:本研究主要探讨超低剂量放疗(RT)治疗原发性和继发性眼附件淋巴瘤(OAL)的疗效和2年预后:对2017年至2022年间接受4 Gy RT治疗的OAL患者进行回顾性分析。评估的主要和次要结果是反应率、无进展生存期和淋巴瘤相关死亡:共纳入21名原发性和继发性OAL患者,患者的表现、亚型和分期各不相同。眼眶肿瘤的平均大小为 17 × 16 × 16 毫米。在14例原发性OAL中,3例(14%)为T1N0M0,8例(38%)为T2N0M0,3例(14%)为T3N0M0(AJCC第八版分期);在7例继发性OAL中,4例(19%)为IE期,2例(10%)为IIE期,1例(5%)为IIIE期(Ann Arbor分期)。超低剂量 RT 治疗 2 年后,局部和全身的完全反应率为 95%,无进展生存率为 100%。14%的患者在治疗后期出现轻度干眼症:结论:超低剂量 RT 是一种有效且耐受性良好的 OAL 治疗方法。我们的研究结果支持使用 4 Gy,在平均 27 个月的随访中,完全反应率高(95%),疾病控制持久,无明显局部复发。我们的研究结果与之前的研究结果一致,验证了超低剂量 RT 的治疗潜力,并强化了以最小干预取得良好疗效的理念。这种方法有可能减轻较高辐射剂量带来的长期眼部副作用,从而提高 OAL 患者的整体生活质量。
{"title":"Two-year Outcomes of Ultra-low-dose Radiotherapy in the Treatment of Ocular Adnexal B-cell Lymphomas.","authors":"Alexandra I Manta, David J Schlect, Delia D Wang, Timothy J Sullivan","doi":"10.1097/IOP.0000000000002747","DOIUrl":"10.1097/IOP.0000000000002747","url":null,"abstract":"<p><strong>Background: </strong>This study focuses on the efficacy and 2-year outcomes of ultra-low-dose radiotherapy (RT) in treating primary and secondary ocular adnexal lymphoma (OAL).</p><p><strong>Methods: </strong>A retrospective analysis was conducted on patients with OAL between 2017 and 2022, treated with 4 Gy of RT. The primary and secondary outcomes assessed were response rate, progression-free survival, and lymphoma-related death.</p><p><strong>Results: </strong>Twenty-one patients with primary and secondary OAL of diverse, presentations, subtypes, and stages were included. The orbital tumors had an average size of 17 × 16 × 16 mm. Of the 14 primary OAL cases, 3 (14%) had T1N0M0 disease, 8 (38%) T2N0M0, and 3 (14%) T3N0M0 (AJCC 8th edition staging); of the 7 secondary OALs, 4 (19%) were stage IE, 2 (10%) stage IIE, and 1 (5%) stage IIIE (Ann Arbor staging). Ultra-low-dose RT yielded a 95% complete response rate and 100% progression-free survival rates, both locally and systemically at 2 years. Mild dry eyes were reported in 14% of patients as a late treatment toxicity.</p><p><strong>Conclusions: </strong>Ultra-low-dose RT emerges as an effective and well-tolerated treatment approach for OAL. Our findings support the use of 4 Gy, showcasing high complete response rates (95%) and durable disease control without significant local relapses over an average follow up of 27 months. Our results align with earlier investigations, validating the curative potential of ultra-low-dose RT and reinforcing the concept of achieving favorable outcomes with minimal intervention. This approach may potentially alleviate the burden of long-term ocular side effects associated with higher radiation doses, enhancing the overall quality of life for OAL patients.</p>","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":" ","pages":"94-100"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142000484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Numerical Aberrations of the Extraocular Muscles and the Levator Palpebrae Superioris: An Anatomical and Clinical Insight. 眼外肌和上睑提肌的数字畸变:解剖学和临床启示。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-10 DOI: 10.1097/IOP.0000000000002807
Hatem A Tawfik, Omar Amro El Houssieny, Jonathan J Dutton

Purpose: To comprehensively review the literature about numerical aberrations of the orbital muscles of ocular motility (here referred to as extraocular muscles [EOMs]) and the levator palpebrae superioris (LPS).

Methods: The authors summarize the embryologic bases and the possible etiopathogenetic causes of numerical aberrations of the EOMs and the LPS and organize these lesions into several broad categories. The clinical and radiologic diagnostic challenges are discussed.

Results: Numerical aberrations of the EOMs include: 1) the complete absence of EOMs, 2) duplication of an entire EOM, 3) the presence of muscle bands that connect 2 EOMs, and 4) minor morphological variations such as bifid muscles (partial splitting of the muscle). Some cases may defy categorization into any of the above or may resemble atavistic remnants of the retractor bulbi muscle. Broadly speaking, numerical aberrations of the LPS generally fall into the same categories although the LPS has several peculiar numerical anomalies of its own.

Conclusions: Although numerical EOM and LPS variations are relatively rare and of little clinical significance, raising awareness about their presence is a fundamental clinical keystone not just for the strabismus surgeon but for the orbital surgeon as well. During orbital surgery, this may spare the surgeon from pursuing an orbital witch hunt for these benign innocuous accessory orbital structures that were accidentally discovered by the radiologist and misinterpreted as sinister etiologies. For the strabismus surgeon, the failure to identify them may result in an unfavorable surgical outcome if these structures are missed because of a lack of awareness despite being responsible for generating complex strabismus patterns or having a restrictive potential of their own.

目的:全面综述有关眼球运动眶肌(此处称为眼外肌[EOMs])和上睑提肌(LPS)数字畸变的文献:作者总结了眼外肌和上睑提肌数字畸变的胚胎学基础和可能的病因,并将这些病变分为几大类。结果:EOMs的数字畸变包括结果:EOM 的数字畸变包括:1)EOM 完全缺失;2)整个 EOM 重复;3)存在连接 2 个 EOM 的肌带;4)轻微的形态变化,如二叉肌(肌肉部分分裂)。有些病例可能无法归类为上述任何一种情况,或者类似于牵张球部肌的残余。大体上说,LPS的数字畸变通常属于同一类别,尽管LPS本身也有几种特殊的数字异常:虽然EOM和LPS的数字变异相对罕见,临床意义也不大,但提高对其存在的认识不仅是斜视外科医生的临床基础,也是眼眶外科医生的临床基础。在眼眶手术过程中,这可能会使外科医生免于对这些良性无害的附属眼眶结构进行 "猎巫",因为放射科医生无意中发现了这些结构,并将其误解为险恶的病因。对于斜视外科医生来说,如果由于缺乏认识而漏诊了这些结构,尽管它们能产生复杂的斜视模式或具有自身的限制潜能,但未能识别它们可能会导致不利的手术结果。
{"title":"Numerical Aberrations of the Extraocular Muscles and the Levator Palpebrae Superioris: An Anatomical and Clinical Insight.","authors":"Hatem A Tawfik, Omar Amro El Houssieny, Jonathan J Dutton","doi":"10.1097/IOP.0000000000002807","DOIUrl":"10.1097/IOP.0000000000002807","url":null,"abstract":"<p><strong>Purpose: </strong>To comprehensively review the literature about numerical aberrations of the orbital muscles of ocular motility (here referred to as extraocular muscles [EOMs]) and the levator palpebrae superioris (LPS).</p><p><strong>Methods: </strong>The authors summarize the embryologic bases and the possible etiopathogenetic causes of numerical aberrations of the EOMs and the LPS and organize these lesions into several broad categories. The clinical and radiologic diagnostic challenges are discussed.</p><p><strong>Results: </strong>Numerical aberrations of the EOMs include: 1) the complete absence of EOMs, 2) duplication of an entire EOM, 3) the presence of muscle bands that connect 2 EOMs, and 4) minor morphological variations such as bifid muscles (partial splitting of the muscle). Some cases may defy categorization into any of the above or may resemble atavistic remnants of the retractor bulbi muscle. Broadly speaking, numerical aberrations of the LPS generally fall into the same categories although the LPS has several peculiar numerical anomalies of its own.</p><p><strong>Conclusions: </strong>Although numerical EOM and LPS variations are relatively rare and of little clinical significance, raising awareness about their presence is a fundamental clinical keystone not just for the strabismus surgeon but for the orbital surgeon as well. During orbital surgery, this may spare the surgeon from pursuing an orbital witch hunt for these benign innocuous accessory orbital structures that were accidentally discovered by the radiologist and misinterpreted as sinister etiologies. For the strabismus surgeon, the failure to identify them may result in an unfavorable surgical outcome if these structures are missed because of a lack of awareness despite being responsible for generating complex strabismus patterns or having a restrictive potential of their own.</p>","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":" ","pages":"8-21"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Teprotumumab on Eyelid Retraction in Thyroid Eye Disease. 泰普单抗对甲状腺眼病患者眼睑后缩的影响
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-05-09 DOI: 10.1097/IOP.0000000000002707
Eman M Al-Sharif, Jason Zhou, Marissa K Shoji, Kaela Acuff, Catherine Y Liu, Bobby S Korn, Don O Kikkawa

Purpose: This study evaluates the efficacy of teprotumumab in reducing eyelid retraction in thyroid eye disease (TED) patients.

Methods: This retrospective study included patients with active or chronic moderate-to-severe TED who completed at least 4 cycles of teprotumumab. Patients with upper and/or lower eyelid retraction, defined as margin-to-reflex distance (MRD) 1 and/or MRD2 of more than 5 mm, in one or OU were included. The main outcome measure was a change in MRD1 and MRD2 after treatment. Changes in MRD1 and MRD2 were each analyzed for correlation (r) with changes in exophthalmolmetry. Student t test was performed for each comparison, and p values <0.05 were considered significant.

Results: The study included 91 patients, predominantly female (87%), with an average age of 52.02 ± 14.6 years. The mean baseline proptosis measurement was 21.8 ± 2.9 OD and 21.7 ± 3.3 OS. The average MRD1 was 5.5 ± 1.5 OD and 5.4 ± 1.7 OS, and the average MRD2 was 6.1 ± 1.1 OD and 6.2 ± 1.1 OS. The follow-up duration post-treatment was 37.5 ± 31.7 weeks. At first follow-up post-treatment, the mean change in proptosis, MRD1, and MRD2 were -2.6 ± 2.0 OD, -2.5 ± 2.1 OS, -0.8.5 ± 1.4 OD, -0.8 ± 1.0 OS, and -0.7 ± 0.9 OD, -0.8 ± 1.0 OS, respectively. Correlation analysis showed that proptosis reduction was positively correlated with MRD1 and MRD2 reduction at the first post-treatment follow-up (MRD1: r = 0.23, p value < 0.01; MRD2: r = 0.17, p = 0.03].

Conclusion: Teprotumumab treatment improves upper and lower eyelid retraction. The improvement in MRD correlated positively with proptosis reduction, indicating the influence of globe position on eyelid position.

目的:本研究评估了替普鲁单抗在减少甲状腺眼病(TED)患者眼睑回缩方面的疗效:这项回顾性研究纳入了至少完成4个周期替普鲁单抗治疗的活动性或慢性中重度TED患者。研究纳入了上眼睑和/或下眼睑回缩的患者,上眼睑和/或下眼睑回缩的定义是眼睑边缘到反射的距离(MRD)1和/或MRD2超过5毫米。主要结果指标是治疗后MRD1和MRD2的变化。MRD1和MRD2的变化分别与眼外肌测量的变化进行相关性(r)分析。每次比较均进行学生 t 检验,并得出 p 值 结果:研究共纳入 91 名患者,以女性为主(87%),平均年龄(52.02±14.6)岁。基线眼球突出平均测量值为(21.8 ± 2.9)OD 和(21.7 ± 3.3)OS。平均 MRD1 为 5.5 ± 1.5 OD 和 5.4 ± 1.7 OS,平均 MRD2 为 6.1 ± 1.1 OD 和 6.2 ± 1.1 OS。治疗后的随访时间为(37.5 ± 31.7)周。治疗后首次随访时,突眼、MRD1和MRD2的平均变化分别为-2.6±2.0 OD、-2.5±2.1 OS、-0.8.5±1.4 OD、-0.8±1.0 OS和-0.7±0.9 OD、-0.8±1.0 OS。相关性分析表明,在治疗后的首次随访中,突眼的减少与MRD1和MRD2的减少呈正相关(MRD1:r = 0.23,p值< 0.01;MRD2:r = 0.17,p = 0.03]:结论:特普鲁单抗治疗可改善上下眼睑回缩。结论:特普鲁单抗治疗可改善上下眼睑回缩,MRD的改善与眼睑下垂的减轻呈正相关,表明眼球位置对眼睑位置有影响。
{"title":"Effects of Teprotumumab on Eyelid Retraction in Thyroid Eye Disease.","authors":"Eman M Al-Sharif, Jason Zhou, Marissa K Shoji, Kaela Acuff, Catherine Y Liu, Bobby S Korn, Don O Kikkawa","doi":"10.1097/IOP.0000000000002707","DOIUrl":"10.1097/IOP.0000000000002707","url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluates the efficacy of teprotumumab in reducing eyelid retraction in thyroid eye disease (TED) patients.</p><p><strong>Methods: </strong>This retrospective study included patients with active or chronic moderate-to-severe TED who completed at least 4 cycles of teprotumumab. Patients with upper and/or lower eyelid retraction, defined as margin-to-reflex distance (MRD) 1 and/or MRD2 of more than 5 mm, in one or OU were included. The main outcome measure was a change in MRD1 and MRD2 after treatment. Changes in MRD1 and MRD2 were each analyzed for correlation (r) with changes in exophthalmolmetry. Student t test was performed for each comparison, and p values <0.05 were considered significant.</p><p><strong>Results: </strong>The study included 91 patients, predominantly female (87%), with an average age of 52.02 ± 14.6 years. The mean baseline proptosis measurement was 21.8 ± 2.9 OD and 21.7 ± 3.3 OS. The average MRD1 was 5.5 ± 1.5 OD and 5.4 ± 1.7 OS, and the average MRD2 was 6.1 ± 1.1 OD and 6.2 ± 1.1 OS. The follow-up duration post-treatment was 37.5 ± 31.7 weeks. At first follow-up post-treatment, the mean change in proptosis, MRD1, and MRD2 were -2.6 ± 2.0 OD, -2.5 ± 2.1 OS, -0.8.5 ± 1.4 OD, -0.8 ± 1.0 OS, and -0.7 ± 0.9 OD, -0.8 ± 1.0 OS, respectively. Correlation analysis showed that proptosis reduction was positively correlated with MRD1 and MRD2 reduction at the first post-treatment follow-up (MRD1: r = 0.23, p value < 0.01; MRD2: r = 0.17, p = 0.03].</p><p><strong>Conclusion: </strong>Teprotumumab treatment improves upper and lower eyelid retraction. The improvement in MRD correlated positively with proptosis reduction, indicating the influence of globe position on eyelid position.</p>","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":" ","pages":"22-27"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140899299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ocular Adverse Effects of Over-the-Counter Cosmetics and Personal Care Products Reported to the Food and Drug Administration. 向食品药品管理局报告的非处方化妆品和个人护理产品对眼睛的不良影响。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-08-13 DOI: 10.1097/IOP.0000000000002718
Aretha Zhu, Owais M Aftab, Jasmine Mahajan, Cat N Burkat

Purpose: Personal care and cosmetic products can cause periocular and ocular adverse effects (AEs), for example, ocular surface disease, trauma, and hypersensitivity. The publicly available Food and Drug Administration (FDA) Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS) database includes AE reports by consumers, healthcare practitioners, and manufacturers. The purpose of this study was to characterize ophthalmic AE associated with cosmetics and personal care products reported by the FDA CAERS database.

Methods: AE related to the eye or ocular adnexa from cosmetics submitted by consumers, healthcare practitioners, and manufacturers from January 2004 to June 2022 were identified after filtering using the Medical Dictionary for Regulatory Activities coding system. Demographic information, case outcome, and categories of product and AE were included. Chi-square analysis, with statistical significance at a = 0.05, was performed to ascertain variation in ocular, periocular, and general outcomes by product category.

Results: Reports of ophthalmic AEs related to cosmetics per year increased from 2006 to 2018, reaching a maximum of 161 reports in 2018, then decreased from 2018 to 2021. In total, 959 and 1382 unique periocular and ocular AEs were reported. There were 1711 total incidences of reported periocular AEs and 2485 ocular AEs. The most reported periocular AEs were inflammation (770/1711) and hypersensitivity (331/1711). The most reported ocular effects were discomfort (946/2485) and inflammation (709/2485). Ocular, periocular, and general outcomes significantly varied by product category.

Conclusions: Consumers, healthcare practitioners, and manufacturers should be made aware of potential ophthalmic AE and outcomes associated with cosmetics and personal care products.

目的:个人护理和化妆品可引起眼周和眼部不良反应(AEs),例如眼表疾病、外伤和过敏。美国食品和药物管理局(FDA)食品安全与应用营养中心的不良事件报告系统(CAERS)数据库公开了消费者、医疗从业人员和制造商的不良事件报告。本研究的目的是分析 FDA CAERS 数据库报告的与化妆品和个人护理产品相关的眼部不良事件的特征:2004年1月至2022年6月期间,消费者、医疗保健从业者和制造商提交的与化妆品有关的眼部或眼部附件AE,在使用监管活动医学字典编码系统进行过滤后被识别出来。其中包括人口统计学信息、病例结果以及产品和 AE 类别。为了确定不同产品类别在眼部、眼周和一般结果方面的差异,进行了统计显著性为 a = 0.05 的卡方分析:从 2006 年到 2018 年,每年与化妆品相关的眼科 AE 报告都在增加,2018 年达到最高值 161 份报告,然后从 2018 年到 2021 年有所减少。共报告了 959 例和 1382 例独特的眼周和眼部 AE。报告的眼周 AE 总发生率为 1711 例,眼部 AE 总发生率为 2485 例。报告最多的眼周不良反应是炎症(770/1711)和过敏(331/1711)。报告最多的眼部不良反应是不适(946/2485)和炎症(709/2485)。眼部、眼周和一般结果因产品类别不同而有显著差异:结论:消费者、医疗保健从业人员和制造商应了解与化妆品和个人护理产品相关的潜在眼部 AE 和结果。
{"title":"Ocular Adverse Effects of Over-the-Counter Cosmetics and Personal Care Products Reported to the Food and Drug Administration.","authors":"Aretha Zhu, Owais M Aftab, Jasmine Mahajan, Cat N Burkat","doi":"10.1097/IOP.0000000000002718","DOIUrl":"10.1097/IOP.0000000000002718","url":null,"abstract":"<p><strong>Purpose: </strong>Personal care and cosmetic products can cause periocular and ocular adverse effects (AEs), for example, ocular surface disease, trauma, and hypersensitivity. The publicly available Food and Drug Administration (FDA) Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS) database includes AE reports by consumers, healthcare practitioners, and manufacturers. The purpose of this study was to characterize ophthalmic AE associated with cosmetics and personal care products reported by the FDA CAERS database.</p><p><strong>Methods: </strong>AE related to the eye or ocular adnexa from cosmetics submitted by consumers, healthcare practitioners, and manufacturers from January 2004 to June 2022 were identified after filtering using the Medical Dictionary for Regulatory Activities coding system. Demographic information, case outcome, and categories of product and AE were included. Chi-square analysis, with statistical significance at a = 0.05, was performed to ascertain variation in ocular, periocular, and general outcomes by product category.</p><p><strong>Results: </strong>Reports of ophthalmic AEs related to cosmetics per year increased from 2006 to 2018, reaching a maximum of 161 reports in 2018, then decreased from 2018 to 2021. In total, 959 and 1382 unique periocular and ocular AEs were reported. There were 1711 total incidences of reported periocular AEs and 2485 ocular AEs. The most reported periocular AEs were inflammation (770/1711) and hypersensitivity (331/1711). The most reported ocular effects were discomfort (946/2485) and inflammation (709/2485). Ocular, periocular, and general outcomes significantly varied by product category.</p><p><strong>Conclusions: </strong>Consumers, healthcare practitioners, and manufacturers should be made aware of potential ophthalmic AE and outcomes associated with cosmetics and personal care products.</p>","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":" ","pages":"61-66"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141971553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Algorithmic Role of Critical Radiographic Features in the Treatment of Angioinvasive Fungal Sinusitis. 关键影像学特征在血管侵袭性真菌性鼻窦炎治疗中的算法作用》(The Algorithmic Role of Critical Radiographic Features in the Treatment of Angioinvasive Fungal Sinusitis)。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-09-06 DOI: 10.1097/IOP.0000000000002783
Alexis Kassotis, Allison Coombs, Nahill Matari, Angela Lignelli, Michael Kazim

Introduction: Angioinvasive fungal sinusitis (AIFS) is a rapidly progressive, highly morbid infection. It can be challenging to obtain an early diagnosis, but intervention in the acute period is crucial for prognosis. Previous literature has identified numerous radiographic features with high sensitivity and specificity for AIFS, even in early disease. Bedside nasal endoscopy can substantiate the diagnosis but can also yield false negative results. Initially, these patients may present to the ophthalmologist. Thus, to avoid visual and potentially life-threatening complications, subtle clinical signs in conjunction with suspicious radiographic features must be promptly recognized by the ophthalmologist and escalated appropriately. We review, for the benefit of the ophthalmic community, the salient radiographic features of AIFS and integrate them into a decision-making algorithm for diagnostic workup and management.

Methods: A literature search was conducted using a comprehensive keyword search in the Pubmed and Embase databases. English studies from 1988 to 2022 describing the radiographic features of AIFS queried. Literature on the newly described entity, COVID-19 COVID-19-associated mucormycosis was included. The authors collected the most frequently reported indicators of AIFS.

Results: The authors review 4 radiographic findings that are frequently associated with AIFS, including in the early stages of disease: 1) loss of contrast enhancement in the nasal turbinate and maxilla (i.e., "black turbinate and maxillary sign"), (2) periantral involvement seen as changes in density, fat stranding or obliteration of the anterior, retromaxillary, or retroantral fat planes on CT, (3) Tissue invasion without bony erosion, (4) Hypointense T2W sinonasal secretions on MRI in the setting of acute sinusitis. The authors additionally propose an algorithm that suggests surgical exploration for patients with clinical concern for AIFS and these radiographic features, even if bedside nasal endoscopy is inconsistent with AIFS.

Conclusion: The radiographic signs highlighted herein should heighten suspicion for AIFS in the appropriate clinical setting, prompting urgent surgical exploration regardless of nasal endoscopy findings.

简介血管侵袭性真菌性鼻窦炎(AIFS)是一种进展迅速、发病率极高的感染。早期诊断具有挑战性,但在急性期进行干预对预后至关重要。以往的文献已发现许多放射学特征对 AIFS 具有高度敏感性和特异性,即使在疾病早期也是如此。床旁鼻内窥镜检查可确诊,但也可能出现假阴性结果。最初,这些患者可能会去看眼科医生。因此,为了避免视觉并发症和潜在的生命危险,眼科医生必须及时发现细微的临床症状和可疑的影像学特征,并进行适当的升级。为了眼科界的利益,我们回顾了 AIFS 的突出放射学特征,并将其纳入诊断工作和管理的决策算法中:方法:在 Pubmed 和 Embase 数据库中使用综合关键词进行文献检索。方法:在 Pubmed 和 Embase 数据库中使用综合关键词进行了文献检索,查询了 1988 年至 2022 年描述 AIFS 影像学特征的英文研究。还包括新描述的实体--COVID-19 COVID-19相关粘液瘤病的文献。作者收集了最常报道的AIFS指标:结果:作者回顾了与 AIFS(包括在疾病的早期阶段)经常相关的 4 个放射学发现:1)鼻甲和上颌骨造影剂增强消失(即 "黑色鼻甲和上颌骨征");(2)CT 表现为密度变化、脂肪绞窄或前方、腋后或腋后脂肪平面阻塞的窦周受累;(3)无骨侵蚀的组织侵犯;(4)急性鼻窦炎时 MRI 表现为低密度 T2W 窦分泌物。此外,作者还提出了一种算法,建议临床关注 AIFS 并具有这些放射学特征的患者进行手术探查,即使床旁鼻内镜检查与 AIFS 不一致:结论:本文强调的放射学征象应在适当的临床环境中提高对 AIFS 的怀疑,无论鼻内镜检查结果如何,都应立即进行手术探查。
{"title":"The Algorithmic Role of Critical Radiographic Features in the Treatment of Angioinvasive Fungal Sinusitis.","authors":"Alexis Kassotis, Allison Coombs, Nahill Matari, Angela Lignelli, Michael Kazim","doi":"10.1097/IOP.0000000000002783","DOIUrl":"10.1097/IOP.0000000000002783","url":null,"abstract":"<p><strong>Introduction: </strong>Angioinvasive fungal sinusitis (AIFS) is a rapidly progressive, highly morbid infection. It can be challenging to obtain an early diagnosis, but intervention in the acute period is crucial for prognosis. Previous literature has identified numerous radiographic features with high sensitivity and specificity for AIFS, even in early disease. Bedside nasal endoscopy can substantiate the diagnosis but can also yield false negative results. Initially, these patients may present to the ophthalmologist. Thus, to avoid visual and potentially life-threatening complications, subtle clinical signs in conjunction with suspicious radiographic features must be promptly recognized by the ophthalmologist and escalated appropriately. We review, for the benefit of the ophthalmic community, the salient radiographic features of AIFS and integrate them into a decision-making algorithm for diagnostic workup and management.</p><p><strong>Methods: </strong>A literature search was conducted using a comprehensive keyword search in the Pubmed and Embase databases. English studies from 1988 to 2022 describing the radiographic features of AIFS queried. Literature on the newly described entity, COVID-19 COVID-19-associated mucormycosis was included. The authors collected the most frequently reported indicators of AIFS.</p><p><strong>Results: </strong>The authors review 4 radiographic findings that are frequently associated with AIFS, including in the early stages of disease: 1) loss of contrast enhancement in the nasal turbinate and maxilla (i.e., \"black turbinate and maxillary sign\"), (2) periantral involvement seen as changes in density, fat stranding or obliteration of the anterior, retromaxillary, or retroantral fat planes on CT, (3) Tissue invasion without bony erosion, (4) Hypointense T2W sinonasal secretions on MRI in the setting of acute sinusitis. The authors additionally propose an algorithm that suggests surgical exploration for patients with clinical concern for AIFS and these radiographic features, even if bedside nasal endoscopy is inconsistent with AIFS.</p><p><strong>Conclusion: </strong>The radiographic signs highlighted herein should heighten suspicion for AIFS in the appropriate clinical setting, prompting urgent surgical exploration regardless of nasal endoscopy findings.</p>","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":" ","pages":"1-7"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142140706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply Re: "Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease". 回复:“Teprotumumab用于治疗顽固性甲状腺眼病”。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2025-01-03 DOI: 10.1097/IOP.0000000000002875
Clara J Men, Linus Amarikwa, Brandon Pham, Connie Sears, Kevin Clauss, Bradford W Lee, Wendy W Lee, Joshua Pasol, Shoaib Ugradar, Roman Shinder, Kimberly Cockerham, Sara Wester, Raymond Douglas, Andrea Lora Kossler
{"title":"Reply Re: \"Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease\".","authors":"Clara J Men, Linus Amarikwa, Brandon Pham, Connie Sears, Kevin Clauss, Bradford W Lee, Wendy W Lee, Joshua Pasol, Shoaib Ugradar, Roman Shinder, Kimberly Cockerham, Sara Wester, Raymond Douglas, Andrea Lora Kossler","doi":"10.1097/IOP.0000000000002875","DOIUrl":"https://doi.org/10.1097/IOP.0000000000002875","url":null,"abstract":"","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":"41 1","pages":"111-112"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142927632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mohs Micrographic Surgery With Immunohistochemistry for the Treatment of Periocular Melanoma In Situ. 利用免疫组化技术进行莫氏显微摄影手术治疗眼周原位黑色素瘤。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-06-17 DOI: 10.1097/IOP.0000000000002729
Kerri M McInnis-Smith, Eucabeth M Asamoah, Addison M Demer, Kannan Sharma, Caroline Y Yu, Elizabeth A Bradley, Andrea A Tooley, Lilly H Wagner

Purpose: Mohs micrographic surgery with immunohistochemistry allows for same-day comprehensive margin assessment of melanoma in situ prior to subspecialty reconstruction. This study describes the oncologic and reconstructive outcomes of eyelid and periorbital melanoma in situ and identifies risk factors for complex reconstructive demands.

Methods: Retrospective case series of all patients treated with Mohs micrographic surgery with immunohistochemistry for melanoma in situ affecting the eyelids or periorbital region from 2008 to 2018 at a single institution. Tumors were assigned to the eyelid group if the clinically visible tumor involved the skin inside the orbital rim. Reconstructive variables were compared between the eyelid and periorbital cohorts.

Results: There were 24 eyelid and 141 periorbital tumors included. The initial surgical margin for all tumors was 5.34 ± 1.54 mm and multiple Mohs stages were required in 24.2% of cases. Eyelid tumors included more recurrences ( p = 0.003), and the average defect size was larger (14.0 ± 13.3 cm 2 vs. 7.7 ± 5.4 cm 2 , p = 0.03). Risk factors for complex reconstruction included: initial tumor diameter >2 cm (odds ratio [OR]: 3.84, 95% confidence interval [CI]: 1.95-7.57) and eyelid involved by initial tumor (OR: 4.88, 95% CI: 1.94-12.28). At an average follow-up of 4.8 years, there were no melanoma-related deaths and 1 local recurrence (0.6% recurrence rate).

Conclusions: Mohs micrographic surgery with immunohistochemistry achieves excellent local control rates for periocular melanoma in situ. An initial surgical margin of 5 mm is frequently insufficient to achieve clear margins. The resulting defects are large, and the complexity of reconstruction can be predicted by tumor size and clinical involvement of eyelid skin.

目的:采用免疫组化技术的莫氏显微摄影手术可在亚专科重建前当天对原位黑色素瘤进行全面的边缘评估。本研究描述了眼睑和眶周原位黑色素瘤的肿瘤学和重建结果,并确定了复杂重建需求的风险因素:回顾性病例系列:2008 年至 2018 年期间,在一家机构接受莫氏显微外科手术治疗的所有眼睑或眶周原位黑色素瘤免疫组化患者。如果临床可见的肿瘤累及眶缘内的皮肤,则将肿瘤归入眼睑组。比较了眼睑组和眶周组的重建变量:结果:共纳入24例眼睑肿瘤和141例眶周肿瘤。所有肿瘤的初始手术切缘为 5.34 ± 1.54 毫米,24.2%的病例需要多次莫氏手术。眼睑肿瘤的复发率更高(p = 0.003),平均缺损面积更大(14.0 ± 13.3 cm2 vs. 7.7 ± 5.4 cm2,p = 0.03)。复杂重建的风险因素包括:初始肿瘤直径大于2厘米(比值比[OR]:3.84,95% 置信区间[CI]:1.95-7.57)和初始肿瘤累及眼睑(比值比[OR]:4.88,95% 置信区间[CI]:1.94-12.28)。在平均4.8年的随访中,没有黑色素瘤相关死亡病例和1例局部复发病例(复发率为0.6%):结论:采用免疫组化技术的莫氏显微摄影手术对眼周原位黑色素瘤的局部控制率非常高。最初的手术切缘为 5 毫米,但往往不足以达到清晰的切缘。手术造成的缺损较大,重建的复杂程度可通过肿瘤大小和眼睑皮肤的临床受累情况来预测。
{"title":"Mohs Micrographic Surgery With Immunohistochemistry for the Treatment of Periocular Melanoma In Situ.","authors":"Kerri M McInnis-Smith, Eucabeth M Asamoah, Addison M Demer, Kannan Sharma, Caroline Y Yu, Elizabeth A Bradley, Andrea A Tooley, Lilly H Wagner","doi":"10.1097/IOP.0000000000002729","DOIUrl":"10.1097/IOP.0000000000002729","url":null,"abstract":"<p><strong>Purpose: </strong>Mohs micrographic surgery with immunohistochemistry allows for same-day comprehensive margin assessment of melanoma in situ prior to subspecialty reconstruction. This study describes the oncologic and reconstructive outcomes of eyelid and periorbital melanoma in situ and identifies risk factors for complex reconstructive demands.</p><p><strong>Methods: </strong>Retrospective case series of all patients treated with Mohs micrographic surgery with immunohistochemistry for melanoma in situ affecting the eyelids or periorbital region from 2008 to 2018 at a single institution. Tumors were assigned to the eyelid group if the clinically visible tumor involved the skin inside the orbital rim. Reconstructive variables were compared between the eyelid and periorbital cohorts.</p><p><strong>Results: </strong>There were 24 eyelid and 141 periorbital tumors included. The initial surgical margin for all tumors was 5.34 ± 1.54 mm and multiple Mohs stages were required in 24.2% of cases. Eyelid tumors included more recurrences ( p = 0.003), and the average defect size was larger (14.0 ± 13.3 cm 2 vs. 7.7 ± 5.4 cm 2 , p = 0.03). Risk factors for complex reconstruction included: initial tumor diameter >2 cm (odds ratio [OR]: 3.84, 95% confidence interval [CI]: 1.95-7.57) and eyelid involved by initial tumor (OR: 4.88, 95% CI: 1.94-12.28). At an average follow-up of 4.8 years, there were no melanoma-related deaths and 1 local recurrence (0.6% recurrence rate).</p><p><strong>Conclusions: </strong>Mohs micrographic surgery with immunohistochemistry achieves excellent local control rates for periocular melanoma in situ. An initial surgical margin of 5 mm is frequently insufficient to achieve clear margins. The resulting defects are large, and the complexity of reconstruction can be predicted by tumor size and clinical involvement of eyelid skin.</p>","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":" ","pages":"78-83"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141331530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lateral Globe Exposure Associated With Graves Upper Eyelid Retraction: The Influence of the Superior Complex Enlargement and Proptosis. 与巴塞杜氏上眼睑后缩相关的眼球外侧暴露:上睑下垂和上睑下垂复合体扩大的影响
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-07-16 DOI: 10.1097/IOP.0000000000002712
Juliana Guimarães, Denny M Garcia, Antonio Augusto V Cruz

Purpose: To investigate the association of the lateral exposure of the globe with proptosis and the enlargement of the superior complex (SC) (levator palpebrae superioris muscle + superior rectus muscle) in patients with Graves upper eyelid retraction.

Methods: Twenty-eight patients with upper lid retraction secondary to Graves orbitopathy and 28 controls matched by age and gender participated in the study. The variables exophthalmometry, margin-reflex distance 1, and upper lid fissure temporal and nasal areas were assessed. Coronal CT scans were evaluated for the measurement of the SC area. A 5% level of significance was assumed for analysis.

Results: Abnormal temporal nasal area differences (T-N), defined as values above the superior limit of the control distribution (15.58 mm 2 ) were detected in 18 patients. Multiple regression analysis showed a significant correlation of abnormal temporo-nasal asymmetries with the SC area and the proptosis (T-N = -6.7 + 0.62* proptosis + 12.3 SC area, R2 = 0.37; p = 0.003).

Conclusion: The etiology of the enhanced lateral globe exposure is not unifactorial. SC enlargement and, to a lesser extent, proptosis are important factors correlated to lateral globe exposure.

目的:研究巴塞杜氏上睑回缩患者眼球外侧暴露与突眼和上复合体(SC)(睑上提肌+上直肌肌)增大的关系:研究对象包括28名继发于巴塞杜氏眼眶病的上睑后缩患者和28名年龄和性别匹配的对照组患者。研究评估了眼球外测量、睑缘反射距离1、上睑裂颞区和鼻区等变量。对冠状 CT 扫描进行评估,以测量 SC 面积。分析假设显著性水平为 5%:在 18 名患者中发现了颞鼻面积差异(T-N)异常,其定义为高于对照组分布上限值(15.58 平方毫米)。多元回归分析表明,异常的颞鼻不对称与 SC 面积和眼球突出有显著相关性(T-N = -6.7 + 0.62* 眼球突出 + 12.3 SC 面积,R2 = 0.37;P = 0.003):结论:眼球外侧暴露增加的病因并非单一因素。结论:眼球外侧暴露增加的病因并非单一因素,SC 扩大是重要因素,其次是眼球突出。
{"title":"Lateral Globe Exposure Associated With Graves Upper Eyelid Retraction: The Influence of the Superior Complex Enlargement and Proptosis.","authors":"Juliana Guimarães, Denny M Garcia, Antonio Augusto V Cruz","doi":"10.1097/IOP.0000000000002712","DOIUrl":"10.1097/IOP.0000000000002712","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the association of the lateral exposure of the globe with proptosis and the enlargement of the superior complex (SC) (levator palpebrae superioris muscle + superior rectus muscle) in patients with Graves upper eyelid retraction.</p><p><strong>Methods: </strong>Twenty-eight patients with upper lid retraction secondary to Graves orbitopathy and 28 controls matched by age and gender participated in the study. The variables exophthalmometry, margin-reflex distance 1, and upper lid fissure temporal and nasal areas were assessed. Coronal CT scans were evaluated for the measurement of the SC area. A 5% level of significance was assumed for analysis.</p><p><strong>Results: </strong>Abnormal temporal nasal area differences (T-N), defined as values above the superior limit of the control distribution (15.58 mm 2 ) were detected in 18 patients. Multiple regression analysis showed a significant correlation of abnormal temporo-nasal asymmetries with the SC area and the proptosis (T-N = -6.7 + 0.62* proptosis + 12.3 SC area, R2 = 0.37; p = 0.003).</p><p><strong>Conclusion: </strong>The etiology of the enhanced lateral globe exposure is not unifactorial. SC enlargement and, to a lesser extent, proptosis are important factors correlated to lateral globe exposure.</p>","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":" ","pages":"49-51"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141627278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Necrotizing Fasciitis of the Orbit Managed With Temporary Indwelling Retrobulbar Catheter. 使用临时留置视网膜导管治疗眼眶坏死性筋膜炎
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-10 DOI: 10.1097/IOP.0000000000002806
Sruti S Rachapudi, Haochen Xu, Sruti S Akella

Necrotizing fasciitis is a rapidly progressive soft tissue infection with high mortality. Aggressive and often repeated surgical debridements are considered the mainstay of treatment, but these interventions may cause significant postoperative morbidity. In this article, the authors present a rare case of orbital necrotizing fasciitis, which was treated with the use of a temporary indwelling retrobulbar drain for antibiotic delivery to deep orbital tissues, in lieu of aggressive debridement. To the authors' knowledge, this is the first report of this technique.

坏死性筋膜炎是一种进展迅速的软组织感染,死亡率很高。积极且经常重复的手术清创被认为是治疗的主要方法,但这些干预措施可能会导致严重的术后发病率。在本文中,作者介绍了一例罕见的眼眶坏死性筋膜炎病例,该病例在治疗过程中使用了临时留置的球后引流管向眼眶深部组织输送抗生素,而不是进行积极的清创。据作者所知,这是首次报道这种技术。
{"title":"Necrotizing Fasciitis of the Orbit Managed With Temporary Indwelling Retrobulbar Catheter.","authors":"Sruti S Rachapudi, Haochen Xu, Sruti S Akella","doi":"10.1097/IOP.0000000000002806","DOIUrl":"10.1097/IOP.0000000000002806","url":null,"abstract":"<p><p>Necrotizing fasciitis is a rapidly progressive soft tissue infection with high mortality. Aggressive and often repeated surgical debridements are considered the mainstay of treatment, but these interventions may cause significant postoperative morbidity. In this article, the authors present a rare case of orbital necrotizing fasciitis, which was treated with the use of a temporary indwelling retrobulbar drain for antibiotic delivery to deep orbital tissues, in lieu of aggressive debridement. To the authors' knowledge, this is the first report of this technique.</p>","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":" ","pages":"e30-e32"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142740187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ophthalmic Plastic and Reconstructive Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1